心脏健康与认知健康:血压作用的证据
本文综述了血压管理与痴呆风险之间关系的证据,指出SPRINT-MIND试验等近年来证据支持对高危老年人进行血压管理干预,但降压最佳时机和目标值尚未达成共识,需在多样化人群中进一步研究。
要点
- SPRINT-MIND等试验支持对高危老年人进行血压管理以降低痴呆风险。
- 降压的最佳时机和目标值目前证据尚不一致。
- 需在种族多样化人群中使用影像和血液生物标志物开展长期研究。
核心结论
- 血压管理是降低痴呆风险的有前景的干预方向,但最佳降压时机和目标值尚无定论。
研究设计与样本
- 本文为综述,汇总过去5年的随机对照试验证据(最突出为SPRINT-MIND试验)及纵向观察性数据。
主要发现
- 过去5年积累的证据显示,对高危老年人进行血压管理干预有效,最突出证据来自SPRINT-MIND试验。
- 这些发现与纵向观察性数据相结合,但结果在降压最佳时机和目标值上并不一致。
临床怎么用
- 对痴呆高危老年人可考虑血压管理干预,但具体降压时机和目标值需结合个体情况。
局限性
- 现有结果在降压最佳时机和目标值上不一致,且需在种族和民族多样化人群中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The enormous societal and financial burden of Alzheimer's disease and related dementias requires the identification of risk factors and pathways to reduce dementia risk. Blood pressure (BP) management and control is one promising area, in which data have been inconclusive. Accumulating evidence over the past 5 years shows the effectiveness of BP management interventions among older individuals at risk, most notably from the SPRINT-MIND trial. These findings have been coupled with longitudinal observational data. However, to date, the results do not concur on the optimal timing and target of BP lowering, and further study in diverse populations is needed. Given the long preclinical phase of dementia and data supporting the importance of BP control earlier in the lifecourse, long-term interventional and observational studies in ethnically and racially diverse populations, with novel imaging and blood-based biomarkers of neurodegeneration and vascular cognitive impairment to understand the pathophysiology, are needed to advance the field.
引用
- Palta P, Albert MS, Gottesman RF, et al. Heart health meets cognitive health: evidence on the role of blood pressure. Lancet Neurol. 2021. PMID: 34536406. doi:10.1016/S1474-4422(21)00248-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。